Feature|Videos|January 2, 2025
The Future of Regulatory Processes in Cell and Gene Therapy
Transferring knowledge and continuing to work together with regulatory agencies will lead to changes in approval going forward.
Advertisement
Episodes in this series
Regulatory agencies are open to changes within the review process which means the uptake of CAR T-cell therapy will change the landscape itself. This is especially true with large-scale commercialization. Information sharing between global agencies will also be helpful in advancing the science forward.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute
3
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
4
AstraZeneca Stock Becomes UK’s Biggest Stock
5
